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Abstract
Background: X monosomic mice (39,XO) have a remarkably mild phenotype when compared to women with
Turner syndrome (45,XO). The generally accepted hypothesis to explain this discrepancy is that the number of
genes on the mouse X chromosome which escape X inactivation, and thus are expressed at higher levels in
females, is very small. However this hypothesis has never been tested and only a small number of genes have
been assayed for their X-inactivation status in the mouse. We performed a global expression analysis in four
somatic tissues (brain, liver, kidney and muscle) of adult 40,XX and 39,XO mice using the Illumina Mouse WG-6
v1_1 Expression BeadChip and an extensive validation by quantitative real time PCR, in order to identify which
genes are expressed from both X chromosomes.
Results: We identified several genes on the X chromosome which are overexpressed in XX females, including
those previously reported as escaping X inactivation, as well as new candidates. However, the results obtained by
microarray and qPCR were not fully concordant, illustrating the difficulty in ascertaining modest fold changes, such
as those expected for genes escaping X inactivation. Remarkably, considerable variation was observed between
tissues, suggesting that inactivation patterns may be tissue-dependent. Our analysis also exposed several autosomal
genes involved in mitochondrial metabolism and in protein translation which are differentially expressed between
XX and XO mice, revealing secondary transcriptional changes to the alteration in X chromosome dosage.
Conclusions: Our results support the prediction that the mouse inactive X chromosome is largely silent, while
providing a list of the genes potentially escaping X inactivation in rodents. Although the lower expression of
X-linked genes in XO mice may not be relevant in the particular tissues/systems which are affected in human X
chromosome monosomy, genes deregulated in XO mice are good candidates for further study in an involvement
in Turner Syndrome phenotype.
Background
The existence of dimorphic sex chromosomes poses a
challenge to the balance of gene dosage between the
sexes. In mammals, X chromosome inactivation is the
mechanism by which the equality in gene expression
between males and females is restored, through the
transcriptional silencing of one of the X chromosomes
in females. Dosage compensation between X-linked and
autosomal genes is also achieved, through the upregula-
tion of the active X chromosome in females and the sin-
gle X chromosome in males [1].
In eutherian mammals, one X chromosome is ran-
domly inactivated in the cell lineages of the embryo
proper, early in development. The initiation of X-inacti-
vation is controlled by a region on the X chromosome,
the X-Inactivation Centre (XIC in humans and Xic in
mice), which contains the X-Inactive-Specific Transcript
locus (XIST/Xist), a noncoding RNA essential for
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by [2]). The nature of their interactions and the succes-
sion of events that results in the global repression of
X-linked genes are not fully understood, being the focus
of active research [3,4]. Once initiated, a wave of silen-
cing spreads through the entire chromosome and the
transcriptionally silent state is stably maintained on the
inactive X chromosome by various epigenetic modifica-
tions, such as histone modifications and DNA methyla-
tion [2,5] and inherited clonally in subsequent cell
divisions.
Although X inactivation is a very effective mechanism
some genes are expressed from the inactive X chromo-
some [6]. Using in vitro models Carrel and Willard [7]
performed a systematic analysis of human X-linked tran-
scripts and predicted that approximately 15% of the
genes on the human X chromosome escape X inactiva-
tion to variable extents. In the mouse only a few “esca-
pees” have been reported [8-12] and the finding of
differences in the inactivation status of several genes in
a conserved region between the human and mouse X
chromosomes has been taken as evidence that the
mouse X chromosome is depleted of genes escaping X
inactivation [13]. Although the mechanisms of escape
are still poorly understood, from the analysis of
sequence features within the relevant regions in human
and in the mouse, the authors suggested that both geno-
mic context and gene-specific regulatory elements are
involved. In particular, long terminal repeats (LTRs) are
more frequent in a smaller human X chromosome
domain where all genes escape inactivation, compared
to the syntenic region in the mouse, where only one of
the genes, Jarid1c, is expressed from the inactive X [13].
Additionally, several binding sites for the insulator pro-
tein CTCF were identified in the 5’ end of Jarid1c but
not in its human homologue (JARID1C), raising the
hypothesis that this protein may be required to prevent
the spreading of silencing epigenetic marks to Jarid1c,
which is embedded in inactive chromatin on the mouse
X chromosome [14]. Recently, the analysis in female ES
cells of chromatin modifications accompanying XCI has
revealed an increase of H3K27me3 throughout the inac-
tive X chromosome, as inactivation proceeds, and a pre-
ferential localisation of this silencing mark over active
genes [15]. The characterization of a larger number of
genes expressed from the inactive X chromosome in the
two species would certainly contribute to a better
understanding of the process of escape, but a compre-
hensive search for genes escaping inactivation on the
mouse X chromosome is still lacking.
In recent reports, microarray technology was used to
compare gene expression between males and females in
several mouse tissues, from which indirect evidence of
escape from X inactivation can be derived [1,16,17].
Nevertheless in these analyses it is difficult to disentangle
the effects of sex hormones in the regulation of gene
expression and, as later demonstrated using manipulated
mice [18], these are indeed substantial. In the mouse
model used to demonstrate this, the gonadal phenotype
(ovaries or testis) is independent of the sex chromosome
complement (XX or XY) and therefore it circumvents the
confounding effects of differential hormonal status. This
strategy had been previously used by Xu and collabora-
tors to investigate expression levels of several sex-linked
genes in brain and it was demonstrated that Eif2s3x,
Jarid1c, Utx and Usp9x were more highly expressed in
the XX genotype, compared to XY, regardless of the
gonadal phenotype [19-23], which further suggests that
these genes escape X inactivation in the mouse.
The 39,XO mouse is another valuable model to assess
the impact of the number of X chromosomes on the level
of X-linked gene expression in a similar hormonal milieu,
using a simple experimental design. The underlying
assumption is that genes that are expressed from both the
active and inactive X chromosomes would be expressed at
higher levels in the XX females than in their XO litter-
mates. We generated three genotypes (X
mO, X
pOa n d
X
mX
p) using the breeding strategy of Davies et al.[24].
The XO mice are free from cryptic mosaicism and
although the mice are on a random bred genetic back-
ground, all the X chromosomes were recently derived
from a single progenitor and thus should be identical.
X monosomic mice (39,XO) have a remarkably mild
phenotype when compared to women with Turner Syn-
drome (45,XO). In fact, while XO mice are fertile and
do not display major physiological abnormalities, TS
females present ovarian dysgenesis and other anatomical
and physiological abnormalities [25]. A spectrum of
neuropsychological deficits is also associated to X chro-
mosome monosomy in humans and, to some extent, in
the mouse [24-27]. The main candidates for the TS phe-
notype are those genes escaping X inactivation in
humans but not in the mouse. However, the global
degree of escape on the mouse X chromosome is pre-
sently unknown.
We present a global expression analysis in somatic tis-
sues of XX and XO mice, using a microarray platform
that allows a genome-wide survey of gene expression,
followed by a detailed qPCR inspection of the candidate
genes. Our analysis identified new genes potentially
escaping X inactivation in the mouse and sheds some
light on the transcriptional networks regulated by X-
linked genes which are disturbed in X chromosome
monosomy.
Results
We performed a genome-wide expression profiling in
four different tissues of adult XX and XO mice (brain,
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Page 2 of 12liver, kidney and muscle), using the Illumina Mouse
WG-6 v1_1 Expression BeadChip, which covers more
than 45,000 transcripts and includes 1,326 probes inter-
rogating the X chromosome transcriptome. According
to our manual annotation these correspond to 970 dif-
ferent genes, thus achieving an extensive coverage of the
mouse X chromosome - on the latest Ensembl release
(55, July 2009), approximately 1000 protein coding
genes were annotated on the X chromosome. Brain was
t h et i s s u ew h e r et h el a r g e s tn u m b e ro fp r o b e sw a s
detected (24,873 were called present in at least one of
the samples), while 19,887 probes were detected in liver,
23,427 in kidney and in muscle 21,820. High values
were obtained for the correlation coefficients (r)
between biological replicates (0.98 to 1), indicating that
the platform and methods applied are extremely robust.
This high reproducibility is also likely due to the pooling
of individuals of the same genotype (we analyzed 3
pools of at least two individuals for each genotype),
which minimizes the differences between individuals.
After normalisation the samples were hierarchically
clustered according to their global expression profiles,
to verify the biological accuracy of the data. The sam-
ples clustered primarily by tissue and in general also by
genotype, as expected (results not shown).
In the chosen array platform 19,100 probes represent
unique curated genes in the NCBI RefSeq database
(Build 36, Release 22). We annotated all the remaining
probes, by performing automated blast searches followed
by a manual curation using combined information from
several databases - NCBI http://www.ncbi.nlm.nih.gov,
MGI http://www.informatics.jax.org/ and SOURCE
http://smd.stanford.edu/cgi-bin/source/sourceSearch.
This allowed us to determine the total number of
X-linked transcripts expressed in each tissue and to per-
form a targeted analysis for each dataset. On the X
chromosome the highest number of probes was detected
in brain (725 present in at least one of the pools), while
in liver only 538 were detected; 643 were expressed in
kidney and 605 in muscle.
As a preliminary analysis of autosomal and X-linked
expression in the two groups we plotted the median of
the normalised hybridization signals of the XO mice
against the XX in each of the four tissues analyzed (Fig-
ure 1). In these graphs, the majority of points, represent-
ing both autosomal and X chromosome genes, lie within
a diagonal where expression is equivalent between
groups, indicating that the majority of genes are
expressed at similar levels in the two groups. An
obvious outlier is present in all graphs, representing
Xist, an expected observation since this gene is only
transcribed from the inactive X chromosome in XX
females; a few scattered X-linked genes can be detected
which also lie above the diagonal, particularly in liver.
Differential gene expression on the X chromosome
Recently, several statistical approaches to detect differ-
ential gene expression from microarray data have been
compared [28] and it was established that empirical
Bayes methods perform better than standard t-tests, par-
ticularly when the sample size is small. Therefore, to
test if those genes located on the X chromosome were
differentially expressed between the two groups of mice,
we employed a pairwise comparison using an Empirical
Bayesian approach, limma [29], which fits a linear model
of gene expression to the data. This is a moderate ver-
sion of the t-statistic where the gene-specific variance
estimator takes into account the data from all genes
[30]. This variance stabilising approach is very robust to
between-sample variation. The resulting p-values were
corrected for multiple tests by setting the FDR (False
Discovery Rate) to 0.05 and number of comparisons
equal to the total number of X chromosome probes
detected in each tissue. Finally we tested several candi-
dates by quantitative real time PCR in different tissues.
The probes significantly overexpressed in XX mice are
listed in Table 1, where the respective p-value obtained
from the array data after FDR correction is also indi-
cated. Fold-change (FC) estimates obtained with both
techniques are also included for reference, although
these should be regarded with caution, since they do
not take into account the variation of the samples.
At the 0.05 significance level (adjusted p-value) differ-
ent groups of probes were found to be significant in
each tissue; Xist w a st h eo n l yp r o b es i g n i f i c a n t l yd i f f e r -
ent between the two groups of mice in all tissues (P <
0.0001).
Eif2s3x, which is ubiquitously expressed and known to
escape X-inactivation in both human and mice [11] is
more highly expressed in XX mice in all tissues ana-
lyzed, although in brain the difference did not reach sig-
nificance by microarray. Two of the three probes
present in the array representing Utx,o n eo t h e rw e l l
known escapee [10,12], were significantly different
between groups in our analysis, presenting a FC higher
than 1.3 in all tissues except brain and a third probe
was significant in liver and kidney. Although in brain
none of the probes for this gene was significant, by real
time PCR the corresponding transcript was detected
more abundantly in XX mice (FC = 1.38 ± 0.14; P <
0.05). Jarid1c, also shown to escape X inactivation in the
mouse [8], presented a modest fold change in all tissues,
reaching significance in liver by microarray (FC = 1.12;
P < 0.01) and qPCR (FC = 1.53 ± 0.06; P < 0.05), and in
muscle only by qPCR (1.43 ± 0.01; P < 0.05). In kidney
and brain the difference in Jarid1c expression between
the two groups was not significant.
Only a small number of genes were differentially
expressed between the two genotypes in muscle and
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nificance threshold. However, the established escapees
Eif2s3x and Utx were significantly overexpressed in the
brain of XX females by qPCR, as well as Ddx3x (for-
merly Dbx), a potential escapee that had been found to
be more highly expressed in female compared to male
brain by Northern Blot [19]. In our microarray analysis
Ddx3x was significantly more abundant in XX females
in liver but it did not reach significance in any of the
other tissues tested.
In liver a higher number of probes, corresponding to
31 different genes, were significantly overexpressed in
XX mice (Table 1); Eif2s3x, Utx, Ddx3x and Jarid1c
were all highly significant (P ≤ 0.01). The fold change
differences in expression between the two groups in this
tissue ranged from 1.1 to 1.8 for the probes with signifi-
cant p-values although some were expressed at low
levels in both groups (Ogt, Cetn2, Arhgef6, Jarid1c,
Slc6a8, Sytl4, Was and Gm732). The limma analysis we
performed also produces a B-statistic, the log-odds that
Figure 1 Plots of the normalised hybridisation signals of XO versus XX mice in four tissues. In black are represented autosomal probes
and X-linked genes are in red; the diagonal (in grey) lies at the intersection of points where median expression is equal between groups. The
most noticeable X-linked outlier corresponds to Xist. A- Brain, B- Muscle, C- Liver, D- Kidney.
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additional measure of the strength of each candidate.
The 11 probes presenting the largest p-values in liver all
present a B < 0 and have therefore less than 50% chance
of being differentially expressed. Pgk1,ag e n et h a t
undergoes X inactivation, is amongst these, although
presenting a small FC. We tested one other gene with B
< 0 by qPCR (Pgrmc1) but could not confirm differential
expression (FC= 1 ± 0.21; P > 0.05), advising caution in
considering these 11 genes as differentially expressed.
The array also includes a probe annotated as repre-
senting Sts (Steroid Sulfatase) ,ag e n ei nt h em o u s e
pseudoautosomal region. Keitges et al.[ 3 1 ]h a v es u g -
gested that this gene escapes inactivation, based on the
comparison of the level of enzyme activity in somatic
tissues of XX, XO and XY mice. There are, however
other reports with conflicting results in the literature
[31-33]. According to our microarray analysis Sts is not
differentially expressed in any of the tissues tested and
we were unable to design appropriate primers on exon-
exon boundaries in order to validate our microarray
results by quantitative PCR, since the genomic sequence
of Sts was not available in any of the databases searched
(NCBI, UCSC Genome Browser and Ensembl). A Blat
search http://genome.ucsc.edu/cgi-bin/hgBlat?com-
mand=start of the probe sequence retrieved no matches,
indicating that the gene is not on the current genome
assembly (July 2007). Enox (AK137473), another gene
recently described as escaping X inactivation [34] is not
represented on the array.
We analysed several of the significant genes by both
microarrays and qPCR. At present, a standard definition
of validation of microarray results by qPCR is still lack-
ing and it is common practice to simply compare FC
values. We required significant p-values in both meth-
odologies as criteria for full concordance. This is espe-
cially important when small expression differences
between groups are sought and it is difficult to define a
fold change cut-off value. Five of the genes that were
significant by microarray analysis were tested by qPCR
in all four tissues (Eif2s3x, Utx, Ddx3x, Jarid1c and
2610029G23Rik). Overall, FC estimates obtained by both
methods were roughly concordant and all genes were
significantly overexpressed by qPCR in at least one of
the tissues tested (see Table 1). Pja1 was significant by
microarray in liver but by qPCR the differences did not
reach significance in liver or kidney, the two tissues
where the expression levels allowed the determination
of reliable standard curves, although the FC estimates
obtained were similar. We could not confirm Lamp2
and Nsbp1 overexpression in liver by qPCR (1.04 ± 0.10;
P < 0.05) and therefore these genes were not tested in
the other tissues. Additionally, four of the significant
genes presenting FC < 1.2 were tested (Ogt, Maob,
Ndufa1 and Pnck); by qPCR only Pnck was significantly
overexpressed (FC = 1.22 ± 0.27; P < 0.05).
Amongst the transcripts that reached the significance
level in more than one tissue by both approaches, one
has not been previously described as escaping X inacti-
vation (2610029G23Rik). The function of
2610029G23Rik and its human homologue CXorf26 have
not yet been determined.
Analysis of allelic expression
To definitely prove escape from X inactivation, expres-
sion from both the active and the inactive X chromo-
somes should be demonstrat e d .I d e a l l ys i n g l ec e l l
analysis should be performed, since every female is a
mosaic of cells with either the maternal or the paternal
X chromosome active and therefore in a tissue homoge-
nate of a heterozygous female, expression from both
alleles would be detected not only from those genes
escaping X inactivation but also from inactive genes.
Alternatively a system in which X inactivation is skewed
towards one of the X chromosomes can be used, such
as 40,T(X;16)16H female mice carrying the Searle’s
translocation. In these females the normal X chromo-
some is always inactive [35] and therefore biallelic
expression, detected through the analysis of sequence
polymorphisms, indicates escape from X inactivation.
We have analysed the transcripts of three of the genes
detected as differentially expressed in our microarray
analysis in cDNA samples of the F1 females of a cross
between a T(X;16)16H female, kept on a mixed C3H/He
and 129/Sv background, and a FVB/NHsd male. Two of
the F1 females from this cross presented DNA sequence
polymorphisms within the coding region and/or the
UTRs of Huwe1, Arhgef6 and Nsbp1; however, for all
three genes tested, at the cDNA level only the allele
derived from the active X chromosome was detected by
direct sequencing and single-base primer-extension
(SNaPshot) (Table 2). The second method is also based
in a fluorescent dideoxy terminator reaction and has
been applied previously to the detection of allele-specific
expression on the X chromosome [7]. We were there-
fore unable to demonstrate expression from both X
chromosomes, for these candidate genes.
Secondary transcriptional alterations
In view of the larger number of X-linked probes found
to be more highly expressed in the liver of XX mice, we
performed a second analysis including all probes in the
array which were detected in this tissue, to verify if any
autosomal transcripts were deregulated between the two
groups of mice. In this genome-wide analysis 1402
probes (out of 19,887) were significantly different
between genotypes at the 0.05 significance level after
correcting for the number of genes tested (see
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Page 6 of 12Additional file 1); of these, 686 (34 annotated to the
X-linked and 584 to the autosomes) were detected more
abundantly in XX mice, while the remaining 716 (14
annotated to the X chromosome and 673 to the auto-
somes) were more highly expressed in the XO genotype.
We confirmed by qPCR one of the autosomal genes sig-
nificantly overexpressed in XX females in liver, Argini-
nosuccinate synthetase 1, Ass1 (FC = 1.49 ± 0.27; P <
0.05), which codes for one of the enzymes of the argi-
nine biosynthetic pathway. Interestingly, the autosomal
genes Eif2b2 and Eif2b5, which encode two of the subu-
nits of the eukaryotic translation initiation factor 2B,
were amongst the most significant probes in this gen-
ome-wide comparison (P = 0.005 and P = 0.007, respec-
tively). In humans, mutations in these genes have been
detected in females with POF (Premature Ovarian Fail-
ure) and it has been hypothesized that EIF2B2 dysfunc-
tion in humans may be related to increased apoptosis of
ovarian follicles [36].
To further clarify if the alterations observed in autoso-
mal gene expression were specific to liver, and are thus
more likely downstream effects of the differential
expression detected for several X-linked genes in this
tissue, we extended the genome-wide statistical analysis
to the remainder of the tissues. In kidney and muscle
datasets only a small number of genes were detected as
differentially expressed at a 0.05 significance level after
FDR correction (6 genes in kidney: Clic6,
2510022D24Rik, Erdr, 11810009N02Rik, LOC100047358,
Rtn4; 3 genes in muscle: Kremen, Casq1, Rab33b).
Therefore the autosomal expression perturbations were
more pervasive in the liver of monosomic mice, where
the differences in X-linked expression are more
pronounced.
Enrichment of functional categories
We performed a functional enrichment analysis for the
liver dataset in FatiGO http://www.babelomics.org/, by
comparing the Gene Ontology (GO) terms corresponding
to the significant genes detected at the genome-wide level
(1340 annotated genes after removing duplicates; Addi-
tional file 1) to the list of all probes present in the array
(14,964 annotated probes after removing duplicates), by
means of a Fisher’s exact test.
Several terms related to metabolic and biosynthetic
pathways, namely energy metabolism, were overrepre-
sented in the set of significant genes and cytoplasmic/
mitochondrial subcellular location was also more fre-
quent (Table 3). Several of the genes coding for NADH
dehydrogenase subunits, the first enzyme (complex I) of
the mitochondrial electron transport chain, are differen-
tially expressed between XX and XO mice, although
there is no clear trend towards an up- or down-regula-
tion of the autosomal components of this enzymatic
complex. Ndufa1, the subunit encoded by an X-linked
gene, is significantly overexpressed in XX females by
microarray but not by qPCR. The modest increase in
expression of this gene, as well as the differences found
in other energy metabolism genes, such as Cytochro-
meb5 Reductase1 (Cyb5r1)a n dt h eCrystallin Zeta qui-
none reductase (Cryz), and in genes encoding other
mitochondrial proteins, may be due to a global altera-
tion of the gene expression networks relevant for mito-
chondrial metabolism.
Table 2 Allelic expression analysis in T16H mice
Female 1 Female 2
gDNA cDNA gDNA cDNA
Huwe1 rs29297624 CT C CT C
rs29296351 CG G CG G
rs29294894* GT G GT G
rs29295859 CT C CT C
Arhgef6 rs13475263* AC A AC A
Nsbp1 rs29091513* CT C CT C
Allelic expression of X chromosome genes in two F1 females, from a cross of
a 40,T(X;16)16H female and an FVB/NHsd male, detected in genomic DNA
(gDNA) and in cDNA from different tissues (liver, kidney, muscle and brain).
All SNPs in the table were analysed by direct sequencing in liver; those
marked as * were also verified by SNaPshot in liver, kidney, muscle and brain.
In all cases only the allele on the X chromosome carrying the translocation
(active) was detected in the cDNA.
Table 3 GO biological processes overrepresented in the
list of deregulated genes in liver
GO group P-value
cytoplasmic part (GO:0044444) 3,35E-10
cytoplasm (GO:0005737) 2,11E-09
mitochondrion (GO:0005739) 6,64E-07
ribonucleoprotein complex (GO:0030529) 1,23E-04
mitochondrial part (GO:0044429) 1,92E-04
intracellular part (GO:0044424) 1,19E-03
biosynthetic process (GO:0009058) 1,69E-03
organelle envelope (GO:0031967) 1,85E-03
organelle inner membrane (GO:0019866) 2,22E-03
cellular metabolic process (GO:0044237) 4,51E-03
intracellular (GO:0005622) 6,98E-03
membrane-bound organelle (GO:0043227) 7,50E-03
organelle part (GO:0044422) 7,50E-03
ribosome (GO:0005840) 1,24E-02
cellular biosynthetic process (GO:0044249) 1,60E-02
organelle membrane (GO:0031090) 1,65E-02
translation (GO:0006412) 1,66E-02
intracellular membrane-bound organelle (GO:0043231) 2,52E-02
intracellular organelle part (GO:0044446) 2,52E-02
proteasome complex (sensu Eukaryota) (GO:0000502) 4,21E-02
intracellular organelle (GO:0043229) 4,21E-02
Functional groups regulated in liver whole genome analysis. Functional
enrichment analysis performed in FatiGO http://www.babelomics.org/ by
Fisher’s exact test followed by FDR correction considering the number of
functional groups tested.
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Considering that several functional categories are over-
represented in our liver dataset it is plausible that the
expression of some X chromosome genes may be per-
turbed indirectly through the action of shared transcrip-
tion factors within an expression network. To further
explore this hypothesis we searched for conserved bind-
ing sequences for known transcription factors within the
5000 bp upstream and downstream the TSS of those
genes that were overexpressed in XX compared to XO
females and performed an analysis of TFBS enrichment
using the oPOSSUM web tool http://www.cisreg.ca/
oPOSSUM/. Following FDR correction the genes over-
expressed in liver showed enrichment for six transcrip-
tion factors (NKX3-1, Lhx3, HLF, Foxa2, Prrx2, Foxd3;
P < 0.05, Fisher’s exact test).
Interestingly, several overexpressed genes located on
the X chromosome, including Huwe1, Arhgef6 and
Nsbp1, present TFBS for one or more of these transcrip-
tion factors. It seems plausible that in XX females higher
transcriptional output of some of the genes that escape X
inactivation may lead to a secondary upregulation of
other genes on the X chromosome belonging to the same
transcriptional networks, which will therefore be overex-
pressed even though not escaping X-inactivation.
Discussion
In the present analysis we aimed to detect differences in
X-linked expression between XX and XO mouse females
in four different tissues, to fully characterize the genes
escaping X inactivation in this model and to increase
our understanding of the basis of the different pheno-
types of X monosomic females in humans and mice.
The identification of genes differentially expressed
through the statistical analysis of microarray data repre-
sents a challenge and the application of this technique
to the identification of genes escaping X inactivation is
of added difficulty. Due to the biological nature of the
differences we were aiming to detect, i.e., expression
from the active X chromosome, which is inherently
upregulated [1], and from the inactive X, which should
reach at most half of that of its counterpart, a modest
overexpression of a maximum of 1.5-fold is expected
between groups for those genes escaping inactivation
[37]. In fact, it has been demonstrated experimentally
that expression from the inactive X chromosome, com-
pared to the active X, can be as low as 5%-15% [7].
Therefore, minor differences between XX and XO mice
for genes escaping X inactivation are not unexpected.
While there was an overall agreement on the direction
of change obtained by microarray and qPCR in our
study, the concordance between the two approaches was
not complete. It is widely accepted that several factors
can contribute to discrepancies between microarray and
qPCR data and each technique presents advantages and
pitfalls. In a recent assessment it has been established
that even though lower fold changes in microarray data
(<1.4) are less likely to be confirmed by qPCR, the most
determinant factor in obtaining a high correlation for
these two approaches is the microarray data p-value
[38]. The same trend is supported by our results.
The most consistent results across tissues, obtained by
both methods, were those of two of the genes previously
demonstrated to escape X inactivation, Eif2s3x and Utx,
and for a new candidate gene (2610029G23Rik). Jarid1c,
also known to escape X inactivation, and Ddx3x,a
potential escapee, only reached significance by both
methods in liver. Variable expression from the inactive
X chromosome across tissues has been reported for Jar-
id1c [39,40] and may have a bearing on the results,
since very small expression differences may be beyond
the detection limit of both approaches.
The majority of the genes detected as differentially
expressed were only so in one of the tissues analyzed,
with liver presenting a noticeably larger number of
genes significantly overexpressed. Several factors may
underlie these observations. Variable escape from inacti-
vation has been observed in rodent-human somatic cell
hybrids and in human cell lines [7,41] as well as across
human [42] and mouse tissues [39,40] and therefore
inactivation patterns of some genes may be tissue- or
even cell-type specific. Tissue composition is also likely
to be contributing to the differences observed, particu-
larly in brain, an organ with very complex tissue archi-
tecture, where we and others [43] were unable to detect
significant differences between XX and XO mice by
microarray, even though a high proportion of genes
on the X chromosome are highly expressed in this
tissue [1].
For several genes, more than one probe was detected
and, in many cases, different probes were not concor-
dant in defining a gene as significantly overexpressed,
even in the same tissue. A careful analysis revealed that
those probes with discordant results were often derived
from genomic sequences that were not included in all
transcripts of a given gene. Therefore, the existence of
alternative splicing is contributing to some extent to the
heterogeneity observed between tissues. Additionally,
o u ra n a l y s i so fe n r i c h m e n to ff u n c t i o n a lc a t e g o r i e sa n d
TFBS within the group of differentially expressed genes
suggests that secondary transcriptional regulation has an
impact on the expression level of several X chromosome
genes and regulation at this level is also likely to vary
between tissues.
Even though the global transcriptional output from
the X chromosome is similar in males and in females
[1], two studies of genom e - w i d eg e n ee x p r e s s i o n
reported several genes differentially expressed between
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borators [17] analyzed a large number of individuals
(169 females and 165 males) and found several genes on
the X chromosome more highly expressed in females, in
at least two tissues (of the four included in the analysis).
In this dataset Utx was female-biased in all tissues ana-
lyzed (brain, liver, adipose and muscle) and Eif2s3x,
Ddx3x and 2610029G23Rik were also female-biased in 3
of the four tissues. Only those genes with a minimum of
3-fold differential expression between sexes were
reported by Rinn and colleagues [16] but, in a reanalysis
of their data, we found that Eif2s3x is significantly over-
expressed in female hypothalamus; Utx, Ddx3x and
2610029G23Rik,a m o n g s to t h e r s ,p r e s e n t e daf o l d
change of 1.2 or higher in at least one of the tissues
(kidney, liver and hypothalamus), although not reaching
the threshold of significance. The fact that a much lar-
ger number of genes is female-biased in at least two tis-
sues (56 genes at P < 0.05) in the comparison
performed by Yang et al. [17] is most likely due to their
larger sample size. Although some of these differences
may be caused by other factors not directly related to
the chromosome complement, such as sex-specific hor-
monal influences, the fact that several of the genes were
consistently overexpressed in both male/female compari-
sons and in our analysis of XX and XO mice suggests
that some may indeed escape X inactivation. In agree-
ment with these results, Ddx3x is indeed expressed from
the inactive X chromosome in the mouse (L. Carrel,
personal communication).
In our study, two new candidates tested were concor-
dant at P < 0.05 by both approaches, in at least one of
the tissues (2610029G23Rik and Pnck). Although higher
expression of Pja1 in the liver and kidney of XX females
was also observed by qPCR, the difference did not reach
significance by this method. Both Pnck and Pja1 are
female-biased in the adipose tissue according to the data
of Yang et al.[17]. Additionally, several of the genes that
were significant in liver in our microarray analysis but
were not confirmed by qPCR (Ogt, Maob,Ndufa, Pgrmc1
and Nsbp1)a r ea m o n g s tt h eg e n e st h a ta r ef e m a l e -
biased in at least one tissue, according to the data of
Yang et al. [17]. In the latter study most of the sex dif-
ferences in gene expression were modest (FC < 1.2) and
the authors did not perform qPCR experiments to con-
firm them.
Further evidence in support of the existence of
uncharacterised escapees on the rodent X chromosome
comes from studies in mouse ES cell lines [15,44]. How-
ever, in the absence of direct evidence of escape from X
inactivation from our allele-specific analysis, two alter-
native hypothesis must be considered: i) the three genes
tested (Huwe1, Arhgef6 and Nsbp1) are false positives
generated by the statistical analyses of differential
expression by microarray (both in our study and in the
study of Yang et al.); ii) overexpression of these genes in
XX females may be due to a secondary transcriptional
upregulation of the active X chromosome allele and
does not reflect expression from both X chromosomes,
as discussed above. The former hypothesis would imply
a bias skewing the results in the same direction in two
independent studies using different microarray platforms
and a different study design, which is unlikely. On the
other hand, the fact that these three genes present bind-
ing sites for common transcription factors gives strength
to the second hypothesis, where overexpression of some
X-linked genes would be due to transcriptional upregu-
lation, through the same mechanism that is contributing
to higher expression of several autosomal genes in XX
females.
Our results, as well as the results from other studies
using both in vitro and in vivo models suggest the exis-
tence of tissue- or cell type-specific patterns of X inacti-
vation. However this issue can only be fully addressed
by a thorough gene-by-gene comparison of allelic
expression in single cell versus whole tissue
homogenates.
Relevance for understanding the molecular basis of
Turner Syndrome
In humans, complete or partial monosomy of the X
chromosome results in Turner syndrome. The pheno-
type, which includes ovarian dysgenesis and infertility, is
attributed to a lower dosage of X chromosome genes
escaping inactivation. However, only 5% of the genes on
the human X chromosome that are expressed in lym-
phoblastoid cell lines are significantly overexpressed in
females at the population level [37]. Therefore, only a
small number of genes are predicted to contribute to
dosage imbalances in X chromosome aneuploidies.
We detected lower expression of several X-linked
genes in XO mice. Moreover, a large number of autoso-
mal genes were differently expressed between the two
genotypes in liver, including two genes which are
mutated in POF - Eif2b2 and Eif2b5 [36]. Due to the
high number of genes on the X chromosome involved
in ovarian and oocyte development it will be interesting
in the future to analyse X-linked expression in the
ovary. However the tissue composition of this organ is
highly heterogeneous, including both somatic and germ-
inal cell lineages and therefore reactivation of the inac-
tive X chromosome during oogenesis is a confounding
factor that must be considered.
The analysis of functional enrichment we performed
in the liver dataset revealed other cellular processes that
are differently regulated between the two groups of mice
analyzed - ATP synthesis and mitochondrial metabo-
lism. Impairment of energy metabolism is expected to
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known to play a prominent role in the pathogenesis of
neurological diseases. These results may therefore have
a bearing on some of the observed neuropsychological
deficits of TS. The presence of binding sites for shared
transcription factors within the regulatory regions of the
genes underexpressed in XO mice reinforced the
hypothesis of a deregulation of specific pathways in this
model.
Although X-linked imprinted genes can also contri-
bute to some of the phenotypes observed in TS females,
parental effects on expression have so far only been
detected in some genes of the Xlr family [24,43]. In our
analysis no relevant differences were found between
X
mO and X
pO mice.
Conclusion
We confirmed and extended previous global analysis of X
chromosome gene expression in the mouse and uncov-
ered a dosage-dependent effect on the expression levels
of several X-linked and autosomal genes that cannot be
attributed to sex-specific hormonal influences. Even
though we found strong candidates for escaping X inacti-
vation, the lack of direct evidence of escape for those
genes tested suggests that other factors may underlie the
differences observed between XX and XO mice.
Several X-linked and autosomal genes are deregulated
in XO mice and these are involved in a variety of cellular
functions. We hypothesize that the TS phenotype is par-
tially caused by the additive effect of regulatory perturba-
tions downstream of the under-expressed X-linked genes,
which may differ between tissues and between species.
Moreover, genes escaping inactivation in humans but not
in the mouse may lie in regulatory nodes at the intersec-
tion of a larger number of effectors, having a greater
impact on genome-wide levels of expression.
Methods
Subjects
The mouse models used in our expression analysis were
obtained as described in [24], except that in our experi-
ment the X chromosomes of the random bred MF1
g e n e t i cb a c k g r o u n dd e r i v e df r o mas i n g l ep r o g e n i t o rX
and thus are the same for all individuals analyzed (X
mO,
X
pOa n dX
mX
p). All genotypes were determined by
bone marrow metaphase preparations and in some cases
confirmed by PCR. All animal procedures and breeding
were in accordance with the United Kingdom Animal
Scientific Procedures Act 1986 and were subject to local
ethical review.
RNA extraction
T i s s u e sf r o m1 2w e e ko l dmice were harvested and
stored at -80°C before use. Total RNA was isolated from
homogenized tissues using Trizol reagent (Invitrogen)
and purified using the RNeasy Kit (Qiagen) according to
the manufacturer’s instructions. RNA integrity was veri-
fied by capillary electrophoresis in the Agilent 2100
Bioanalyzer.
Gene expression quantification in 40,XX and 39,XO mice
The RNA samples of seven 40,XX, eight 39,X
pOa n d
eight 39,X
mO mice were pooled by genotype into 9
groups, representing 3 biological replicates per genotype,
as follows: 39,X
pO-1 and 39,X
pO-2 (3 pooled individuals
each), 39,X
pO-3 (2 pooled individuals); 39,X
mO-1 and
39,X
mO - 2( 3p o o l e di n d i v i d u a l se a c h ) ,3 9 , X
mO-3 (2
pooled individuals); 40,XX-1 and 40,XX-2 (3 pooled
individuals each) 40,XX-3 (2 pooled individuals). A total
of 300 ng of RNA from each pool was then amplified
following the Illumina TotalPrep RNA amplification
protocol. The samples were labelled and hybridized to
the Mouse WG-6 v1_1 Expression BeadChip whole gen-
ome expression array available from Illumina, following
the manufacturer’s protocols.
Array data extraction, normalisation and analysis
The values for each bead in the array were imported
into the Illumina software BeadStudio for preliminary
quality checks, summarized according to bead type and
then exported into R environment for statistical com-
puting. Normalisation across all arrays was performed
on a log scale using the quantile normalisation method
[45] implemented in lumi normalisation package [46].
The normalised intensity values were used for indepen-
dent pairwise comparisons for each tissue, using the
empirical Bayes approach implemented in limma by
assigning the samples to two groups according to geno-
type (40,XX and 39,XO). Only probes detected as pre-
sent in at least one the samples in each tissue were
compared. The p-values were then subjected to the FDR
correction[47].
Samples were hierarchically clustered using the tools
implemented in InforSense Workflow Builder http://
www.inforsense.com. The distance matrix was calculated
with Pearson correlation and clusters built by average
linkage.
The microarray data for this study have been depos-
ited to GEO under accession number GSE13520.
Quantitative Real-Time PCR
Quantitative real-time PCR reactions were carried out
using 100 ng of cDNA in a reaction volume of 20 μl com-
prising Sybr Green PCR Master Mix (Applied Biosys-
tems) and 0.3 μM of each primer in an Applied
Biosystems 7000 detection system (Applied Biosystems).
Efficiency of primers and quantity of cDNA in each well
were derived from an experimentally determined
Lopes et al. BMC Genomics 2010, 11:82
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2 ≥ 0.99 and with a
standard curve slope typically -3.1 ≤ S ≤ -3.6 were
accepted. Melt curve data were obtained to confirm
amplification of the correct product. Expression was nor-
malised by reference to Gapdh and in most cases the
results were confirmed using Actb. Differences in expres-
sion between groups were calculated by means of a t-test.
All primers were designed to span exon-exon boundaries,
to prevent amplification of possible genomic DNA con-
taminants. For primer sequences see Additional file 2.
Analysis of allelic expression
Expression from each X chromosome was verified using
polymorphisms within the coding region and/or the
UTRs of Huwe1, Arhgef6 and Nsbp1 by direct sequen-
cing and, whenever possible, by single-base primer-
extension (SNaPshot). Each SNaPshot assay was tested
in genomic DNA of T16H-FVB F1 females heterozygous
for the target SNPs and then used to differentiate
expression from each X chromosome in the cDNAs
from liver, kidney, muscle and brain of two animals.
Typically 50 ng of DNA and 100 ng of cDNA were
amplified using the HotStar HiFidelity Polymerase Kit
(Qiagen) in a 10 μl reaction volume comprising 0.3 μM
of each primer. PCR conditions were the following: 15
min pre-incubation step at 94°C, 35 cycles of denatura-
tion at 94°C for 30 sec, annealing for 45 sec at the
respective AT for each primer pair and extension at 72°
C for 45 sec, followed by a final extension step at 72°C
for 10 min. The PCR products were then purified with
ExoSAP-IT (Usb) and single-base primer-extension reac-
tions were carried out with SNaPshot Multiplex Kit
(Applied Biosystems) in a 5 μl volume comprising 0.2
μM of the extension primer and up to 2 μlo ft h ep u r i -
fied PCR product (depending on the expression level of
each gene in the different tissues tested), for 25 cycles.
SNaPshot reactions were cleaned up with Shrimp Alka-
line Phosphatase (Usb) and the analysis of fluorescent
products was performed in an ABI 3100 sequencer
using the GeneMapper 4.0 Analysis Software. For pri-
mer sequences see Additional file 2.
Additional file 1: Probes differentially expressed in liver of XX and
XO mice. A linear model pairwise comparison between XX and XO mice
was performed using the R package limma for all probes (X
chromosome and autosomal) detected in liver (19,887). After FDR
correction 1402 probes were significantly different between genotypes at
the 0.05 significance level.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2164-11-
82-S1.XLS]
Additional file 2: Primer sequences. This file contains the sequences of
the primers used in qPCR and in the analysis of allelic expression by
SNaPshot.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2164-11-
82-S2.XLS]
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